Formerly, the term pseudopseudohypoparathyroidism (PPHP), was used for patients who display AHO features and carry heterozygous inactivating Gsα mutations without evidence of hormone resistance. The gene discussed is GNAS; the disease is pseudohypoparathyroidism type 1A.